Tag Archives: Health Care

Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree

Dr. Margaret Foti

Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree.  Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science. Dr. Foti is also known for her work leading AACR’s scientific partnership with Stand Up To Cancer — a charitable initiative that supports Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

We Are BIO

Jim Greenwood

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

Ernst & Young

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the state of the biotech industry, Beyond Borders, was buoyed by positive trends outlined in the report that show despite the overall lingering uneasiness in the economy, biotech is continuing its growth momentum. The Super Session at the 2012 BIO International Convention was moderated by members of Ernst & Young’s life sciences leadership team: Glen Giovannetti, Gautam Jaggi and Sanjeev Wadhwa; Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

From Bench to Bedside in a Bioeconomy

lab_tech02-btn

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program when the closing panel reinforces the opening speaker. Boston University President Robert Brown kicked off the afternoon at the Translational Research Forum at the 2012 BIO International Convention by showing how the old linear model of product development crafted after World War II no longer applies. The closing industry panel aptly remarked that a struggling economy has brought the public and private Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech Companies are Bringing Innovation to Global Health

Don Joseph

By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures for Global Health (BVGH) released a report, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape, which showed that small- to medium-sized biotechnology companies are participating in a high percentage (41 percent) of projects targeting neglected diseases of the developing world. The findings of this report were surprising, given the financial risks these companies Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , ,